Abstract
Considering the presence of multiple types of cell death induced by chemicals, it is important to determine a definitive strategy for the exploration of new highly tumor-selective compounds. The screening of highly selective compounds should be performed before the identification of the type of cell death (either apoptosis, autophagy, or necrosis) and the cell death induction mechanism. The tumor specificities of heterocyclic compounds and the type of cell death induced by them are summarized.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wilfried R, Reed JC (2002) Nat Med 8:216
Yu L, Alva A, Su H, Dutt P, Freundt E, Welsh S, Baehrecke EH, Lenardo M (2004) Science 304:1500
Shintani T, Klionsky DJ (2004) Science 306:990
Daido S, Yamamoto A, Fujiwara K, Sawaya R, Kondo S, Kondo Y (2005) Cancer Res 65:4368
Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, Domingo D, Yahalom J (2001) Cancer Res 61:439
Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y, Kondo S (2005) Oncogene 24:980
Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I (2003) Cancer Res 63:2103
Daido S, Kanzawa T, Yamamoto A, Takeuchi H, Kondo Y, Kondo S (2004) Cancer Res 64:4286
Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S (2004) Cell Death Differ 11:448
Yanagisawa-Shiota F, Sakagami H, Kuribayashi N, Iida M, Sakagami T, Takeda M (1995) Anticancer Res 15:259
Iida M, Doi H, Asamoto S, Sugiyama H, Kuribayashi N, Sakagami H, Matsumoto K (1999) Anticancer Res 19:1235
Kuribayashi N, Sakagami H, Iida M, Takeda M (1996) Anticancer Res 16:1225
Broker LE, Kruyt FAE, Giaccone G (2005) Clin Cancer Res 11:3155
Sakagami H, Kawase M, Wakabayashi H, Kurihara T (2007) Autophagy 3:493
Nakayachi T, Yasumoto E, Nakano K, Morshed SRM, Hashimoto K, Kikuchi H, Nishikawa H, Kawase M, Sakagami H (2004) Anticancer Res 24:737
Takeuchi R, Hoshijima H, Onuki N, Nagasaka H, Chowdhury SA, Kawase M, Sakagami H (2005) Anticancer Res 25:4037
Takeuchi R, Hoshijima H, Nagasaka H, Chowdhury SA, Kikuchi H, Kanda Y, Kunii S, Kawase M, Sakagami H (2006) Anticancer Res 26:3343
Ideo A, Sasaki M, Nakamura C, Mori K, Shimada J, Kanda Y, Kunii S, Kawase M, Sakagami H (2006) Anticancer Res 26:4335
Nam S, Smith DM, Dou QP (2001) Cancer Epidemiol Biomarkers Prev 10:1083
Stewart JR, Ward NE, Ioannides CG, O'Brian CA (1999) Biochemistry 38:13244
Sakagami H, Kobayashi M, Chien C-H, Kanegae H, Kawase M (2007) In Vivo 21:311
Takekawa F, Nagumo T, Shintani S, Hashimoto K, Kikuchi H, Katayama T, Ishihara M, Amano O, Kawase M, Sakagami H (2007) Anticancer Res 27(6): (in press)
Suzuki F, Hashimoto K, Ishihara M, Westman G, Samuelsson K, Kawase M, Motohashi N, Sakagami H (2007) Anticancer Res 27(6): (in press)
Kawase M, Tanaka T, Kan H, Tani S, Nakashima H, Sakagami H (2007) In Vivo 21:829
Kawase M, Sakagami H, Hashimoto K, Tani S, Hauer H, Chatterjee SS (2003) Anticancer Res 23:3243
Kawase M, Sakagami H, Motohashi N, Hauer H, Chatterjee SS, Spengler G, Vigyikanne AV, Molnar A, Molnar J (2005) In Vivo 19:705
Sakagami H, Hashimoto K, Suzuki F, Ishihara M, Kikuchi H, Katayama T, Satoh K (2007) Anticancer Res 27(6): (in press)
Grimmett MR (1984) In: Potts KT (ed) Comprehesive heterocyclic chemistry, vol. 5. Pergamon, Oxford, pp 345–498
Bellina F, Cauteruccio S, Rossi R (2007) Tetrahedron 63:4571
Anil KC, Jayarama SB, Salimath BP, Rangappa KS (2007) Invest New Drugs 25:343
Tron GC, Pirali T, Sorba G, Pagliai F, Busacca S, Genazzani AA (2006) J Med Chem 49:3033
Bellina F, Cauteruccio S, Monti S, Rossi R (2006) Bioorg Med Chem Lett 16:5757
Motohashi N, Mitscher LA, Meyer R (1991) Med Res Rev 11:239
Wesolowska O, Molnar J, Westman G, Samuelsson K, Kawase M, Ocsovszki I, Motohashi N, Michalak K (2006) In Vivo 20:109
Thimmaiah KN, Easton JB, Germain GS, Morton CL, Kamath S, Buolamwini JK, Houghton PJ (2005) J Biol Chem 280:31924
Kucukkikinc T, Ozer I (2007) Arch Biochem Biophys 461:294
Cincotta L, Foley JW, Cincotta AH (1993) Cancer Res 53:2571
Shirado K, Imaizumi K, Abe A, Tomoda A (2007) Biol Pharm Bull 30:331
Motohashi N (1993) Yakugaku Zasshi 103:364
Cui Q, Tashiro S, Onodera S, Ikejima T (2006) J Pharmacol Sci 101:230
Nawrot-Modranka J, Nawrot E, Graczyk J (2006) Eur J Med Chem 41:1301
Horton DA, Bourne GT, Smythe ML (2003) Chem Rev 103:893
Sabitha G (1996) Aldrichimica Acta 29:15
Wang B, Yang Z-Y, Li T (2006) Bioorg Med Chem 14:6012
Havsteen BH (2002) Pharmacol Therap 96:67
Nakano K, Nakayachi T, Yasumoto E, Morshed SRMD, Hashimoto K, Kikuchi H, Nishikawa H, Sugiyama K, Amano O, Kawase M, Sakagami H (2004) Anticancer Res 24:711
Foltinova P, Lacova M, Loos D (2000) Farmaco 55:21
Pisco L, Kordian M, Peseke K, Feist H, Michalik D, Estrada E, Carvalho J, Hamilton G, Rando D, Quincoces J (2006) Eur J Med Chem 41:401
Miller D, Wang S, Reid J, Xie W, Gauvin B, Kelley M, Sarup J, Sawutz DG, Miski M, Dolle RE, Faltynek CR (1995) Drug Develop Res 34:344
Barath Z, Radics R, Spengler G, Ocsovszki I, Kawase M, Motohashi N, Shirataki Y, Shah A, Molnar J (2006) In Vivo 20:645
Nohara A, Umetani T, Sanno YA (1974) Tetrahedron 30:3553
Murray RDH, Mendez J, Brown SA (1982) The natural coumarins: occurrence, chemisty and biochemistry. Wiley, New York, p 282
Finn GJ, Creaven BS, Egan DA (2004) Biochem Pharmacol 67:1779
Chuu C-Y, Tsai Y-Y, Wang C-J, Lin W-L, Tseng T-H (2001) Eur J Pharmacol 416:25
Kolodziej H, Kayser O, Woerdenbag HJ, van Uden W, Pras N (1997) Z Naturforsch 52c:240
Paya M, Goodwin PA, de las Heras B, Hoult RS (1994) Biochem Pharmacol 48:445
Sakai I, Hashimoto S, Yoda M, Hida T, Ohsawa S, Nakajo S, Nakaya K (1994) Biochem Biophys Res Commun 205:1305
Kameda T, Miyazawa K, Mori Y, Yuasa T, Shiokawa M, Nakamura Y, Mano H, Hakeda Y, Kameda A, Kumegawa M (1996) Biochem Biophys Res Commun 220:515
Shibayama-Imazu T, Sakairi S, Watanabe A, Aiuchi T, Nakajo S, Nakaya K (2003) J Cancer Res Clin Oncol 129:1
Masuda Y, Yoda M, Ohizumi H, Aiuchi T, Watabe M, Nakajo S, Nakaya K (1997) J Cancer 71:691
Masuda Y, Nakaya M, Aiuchi T, Hashimoto S, Nakajo S, Nakaya K (2000) Leukemia Res 24:937
Sakagami H, Satoh K, Hakeda Y, Kumegawa M (2000) Cell Mol Biol 46:129
Ishihara M, Takayama F, Toguchi M, Nakano K, Yasumoto E, Nakayachi T, Satoh K, Sakagami H (2000) Anticancer Res 20:4307
Okayasu H, Ishihara M, Satoh K, Sakagami H (2001) Anticancer Res 21:2387
Zhang W, Negoro T, Satoh K, Jiang Y, Hashimoto K, Kikuchi H, Nishikawa H, Miyata T, Yamamoto Y, Nakano K, Yasumoto E, Nakayachi T, Mineno K, Satoh T, Sakagami H (2001) Anticancer Res 21:3439
Jamison JM, Gilloteaux J, Nmassiri MR, Venugopal M, Nea DR, Summers JL (2004) Biochem Pharm 67:337
Sakagami H, Fujiwara E, Yokote Y, Akahane K, Asano K, Kochi M, Hara E, Shirahata A (2000) Anticancer Res 20:265
Nakamura C, Yasumoto E, Nakano K, Nakayachi T, Hashimoto K, Kusama K, Fukuda M, Sakashita H, Shirahata A, Sakagami H (2003) Anticancer Res 23:4797
Sakagami H, Satoh K, Ohata H, Takahashi H, Yoshida H, Iida M, Kuribayashi N, Sakagami T, Momose K, Takeda M (1996) Anticancer Res 16:2635
Shibayama-Imazu T, Sonoda I, Sakairi S, Aiuchi T, An W-W, Nakajo S, Itabe H, Nakaya K (2006) Apoptosis 11:1535
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Sakagami, H. et al. (2007). Tumor Specificity and the Type of Cell Death Induced by Heterocycles. In: Motohashi, N. (eds) Bioactive Heterocycles VI. Topics in Heterocyclic Chemistry, vol 15. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7081_2007_103
Download citation
DOI: https://doi.org/10.1007/7081_2007_103
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79217-8
Online ISBN: 978-3-540-79218-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)